52-Year-Old Woman Presenting for Asymmetry of Right Breast: (A) DBT craniocaudal view shows asymmetry (arrow) in medial right breast (DBT). (B) DBT spot compression view shows asymmetry does not persist (arrowhead). Lesion classified on DBT without, and DBT with, DBT spot compression view as BI-RADS category 4a and 2 by reader 1, category 4a and 2 by reader 2, and category 4b and 2 by reader 3. Follow-up imaging at one year demonstrated stability of finding, consistent with benignity in present analysis.

52-Year-Old Woman Presenting for Asymmetry of Right Breast: (A) DBT craniocaudal view shows asymmetry (arrow) in medial right breast (DBT). (B) DBT spot compression view shows asymmetry does not persist (arrowhead). Lesion classified on DBT without, and DBT with, DBT spot compression view as BI-RADS category 4a and 2 by reader 1, category 4a and 2 by reader 2, and category 4b and 2 by reader 3. Follow-up imaging at one year demonstrated stability of finding, consistent with benignity in present analysis.


February 16, 2022—According to an article in ARRS’ American Journal of Roentgenology (AJR), digital breast tomosynthesis (DBT) spot compression view could help characterize equivocal DBT findings, thus reducing further workup for benign findings.

Noting that DBT spot compression increased both intrareader and interreader agreement and improved diagnostic accuracy, primarily from improved specificity, “the view’s supplemental dose was slightly higher than that of a standard DBT view,” corresponding author Foucauld Chamming’s of Institut Bergonié in Bordeaux, France acknowledged.

The all-French team’s retrospective study included 102 women (mean age, 60 years) for whom a DBT spot compression was acquired to characterize an equivocal finding on DBT (via the performing radiologist’s discretion) from December 14, 2018 to December 18, 2019. Conscious of the equivocal lesions’ location, two fellowship-trained breast radiologists and one breast imaging fellow independently reviewed all examinations—assigning an initial BI-RADS category using standard DBT views, immediately followed by a category using DBT spot compression.

Based on kappa coefficients for DBT with and without spot compression views, intrareader agreement increased from 0.43 to 0.72, and interreader agreement increased from 0.21 to 0.45. Additionally, for all three readers, DBT spot compression views yielded significantly increased accuracy, as well as significantly increased specificity.

Adding that their study is the first to evaluate the impact of obtaining DBT spot compression for equivocal findings on DBT, “the results support the utility of spot compression views for aiding evaluation of subtle or ambiguous findings encountered on DBT in clinical practice,” the authors of this AJR article concluded.

For more information: www.arrs.org

Related Digital Breast Tomosynthesis Content:

AI DBT Impact on Mammography Post-breast Therapy

ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs

Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
Subscribe Now